3 ms·
It is about a third. The US government is effective at funding early research but quite poor at funding development, and they ignore some valuable areas of rese
by jandrewrogers 12y ago
It is about a third. The US government is effective at funding early research but quite poor at funding development, and they ignore some valuable areas of research for reason of political optics. Development tends to be where almost all the expense is incurred. In practice, there is a hand-off between government and industry in the transition from research to development because it plays to their respective strengths. Most of the research done by the government, like all such early research, turns out to be medically worthless during development.
Looking at it like a startup, the expected annual return on biomedical R&D if you have a huge portfolio is something like 10% even with the unrecovered government investment. In other words, better than investing in an S&P index fund and worse than broadly investing in early stage tech. Without the early government investing at a loss, it might not even be worth the money of the private sector to follow on for the development compared to other things they could be investing their money in.